This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gentry, L O
Right arrow Articles by Natelson, E A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gentry, L O
Right arrow Articles by Natelson, E A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1985 May; 27(5): 683-684

Effects of apalcillin on platelet function in normal volunteers.

L O Gentry, B A Wood and E A Natelson

ABSTRACT

We investigated the effects of apalcillin on blood coagulation and platelet function. The drug was administered to 21 human volunteers in daily intravenous doses of 75, 150, and 225 mg/kg. These doses evoked abnormalities in platelet aggregation similar to those found with piperacillin and mezlocillin and less striking than those produced by carbenicillin and ticarcillin. Plasma coagulation as measured by prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen concentration was not affected. There were consistent and major reductions in plasma antithrombin III activity, particularly at the two higher dose levels. Of 21 patients, 7 (33%) also manifested maculopapular skin rashes which resolved after discontinuation of the drug.


Antimicrob Agents Chemother. 1985 May; 27(5): 683-684




This article has been cited by other articles:

  • SATTLER, F. R., WEITEKAMP, M. R., BALLARD, J. O. (1986). Potential for Bleeding with the New Beta-Lactam Antibiotics. ANN INTERN MED 105: 924-931 [Abstract]